FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224440106> ?p ?o ?g. }

• W4224440106 endingPage "5555" @default.
• W4224440106 startingPage "5550" @default.
• W4224440106 abstract "Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of aggressive non-Hodgkin lymphomas, the majority of which have high relapse rates following standard therapy. Despite use of consolidative stem cell transplant (SCT) following frontline therapy, there remains no consensus on its utility. The double-blind randomized phase 3 ECHELON-2 study (#NCT01777152; clinicaltrials.gov) demonstrated improved progression-free survival (PFS) and overall survival with frontline brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone (A+CHP). Herein, we conducted an exploratory subgroups analysis of the impact of consolidative SCT on PFS in patients with previously untreated CD30+ PTCL (ALK- anaplastic large cell lymphoma [ALCL] and non-ALCL) who were in complete response (CR) after frontline treatment with A+CHP or cyclophosphamide, doxorubicin, vincristine, and prednisone. Median PFS follow-up was 47.57 months. The PFS hazard ratio was 0.36, equating to a 64% reduction in the risk of a PFS event in patients who underwent SCT. The median PFS in patients who underwent SCT was not reached, vs 55.66 months in patients who did not undergo SCT. PFS results favored the use of SCT in both ALK- ALCL and non-ALCL subgroups. These data support the consideration of consolidative SCT in patients with CD30+PTCL who achieve CR following treatment with A+CHP." @default.
• W4224440106 created "2022-04-27" @default.
• W4224440106 creator A5002126535 @default.
• W4224440106 creator A5011181925 @default.
• W4224440106 creator A5014849816 @default.
• W4224440106 creator A5016734314 @default.
• W4224440106 creator A5017873196 @default.
• W4224440106 creator A5020124946 @default.
• W4224440106 creator A5025794705 @default.
• W4224440106 creator A5031476005 @default.
• W4224440106 creator A5035100399 @default.
• W4224440106 creator A5035649087 @default.
• W4224440106 creator A5036000764 @default.
• W4224440106 creator A5036867361 @default.
• W4224440106 creator A5038596323 @default.
• W4224440106 creator A5044958787 @default.
• W4224440106 creator A5051605599 @default.
• W4224440106 creator A5053851166 @default.
• W4224440106 creator A5058320427 @default.
• W4224440106 creator A5058954518 @default.
• W4224440106 creator A5059661907 @default.
• W4224440106 creator A5060314041 @default.
• W4224440106 creator A5069406522 @default.
• W4224440106 creator A5085712310 @default.
• W4224440106 creator A5088476247 @default.
• W4224440106 creator A5090964554 @default.
• W4224440106 date "2022-10-05" @default.
• W4224440106 modified "2023-10-18" @default.
• W4224440106 title "Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2" @default.
• W4224440106 cites W2033241503 @default.
• W4224440106 cites W2035861968 @default.
• W4224440106 cites W2058767673 @default.
• W4224440106 cites W2059334385 @default.
• W4224440106 cites W2098666639 @default.
• W4224440106 cites W2113994301 @default.
• W4224440106 cites W2133201432 @default.
• W4224440106 cites W2138023339 @default.
• W4224440106 cites W2138498369 @default.
• W4224440106 cites W2143450001 @default.
• W4224440106 cites W2149005508 @default.
• W4224440106 cites W2163510906 @default.
• W4224440106 cites W2416844197 @default.
• W4224440106 cites W2511629593 @default.
• W4224440106 cites W2616318316 @default.
• W4224440106 cites W2772570340 @default.
• W4224440106 cites W2903308035 @default.
• W4224440106 cites W2920983629 @default.
• W4224440106 cites W4200256437 @default.
• W4224440106 doi "https://doi.org/10.1182/bloodadvances.2020003971" @default.
• W4224440106 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35470385" @default.
• W4224440106 hasPublicationYear "2022" @default.
• W4224440106 type Work @default.
• W4224440106 citedByCount "11" @default.
• W4224440106 countsByYear W42244401062022 @default.
• W4224440106 countsByYear W42244401062023 @default.
• W4224440106 crossrefType "journal-article" @default.
• W4224440106 hasAuthorship W4224440106A5002126535 @default.
• W4224440106 hasAuthorship W4224440106A5011181925 @default.
• W4224440106 hasAuthorship W4224440106A5014849816 @default.
• W4224440106 hasAuthorship W4224440106A5016734314 @default.
• W4224440106 hasAuthorship W4224440106A5017873196 @default.
• W4224440106 hasAuthorship W4224440106A5020124946 @default.
• W4224440106 hasAuthorship W4224440106A5025794705 @default.
• W4224440106 hasAuthorship W4224440106A5031476005 @default.
• W4224440106 hasAuthorship W4224440106A5035100399 @default.
• W4224440106 hasAuthorship W4224440106A5035649087 @default.
• W4224440106 hasAuthorship W4224440106A5036000764 @default.
• W4224440106 hasAuthorship W4224440106A5036867361 @default.
• W4224440106 hasAuthorship W4224440106A5038596323 @default.
• W4224440106 hasAuthorship W4224440106A5044958787 @default.
• W4224440106 hasAuthorship W4224440106A5051605599 @default.
• W4224440106 hasAuthorship W4224440106A5053851166 @default.
• W4224440106 hasAuthorship W4224440106A5058320427 @default.
• W4224440106 hasAuthorship W4224440106A5058954518 @default.
• W4224440106 hasAuthorship W4224440106A5059661907 @default.
• W4224440106 hasAuthorship W4224440106A5060314041 @default.
• W4224440106 hasAuthorship W4224440106A5069406522 @default.
• W4224440106 hasAuthorship W4224440106A5085712310 @default.
• W4224440106 hasAuthorship W4224440106A5088476247 @default.
• W4224440106 hasAuthorship W4224440106A5090964554 @default.
• W4224440106 hasBestOaLocation W42244401061 @default.
• W4224440106 hasConcept C126322002 @default.
• W4224440106 hasConcept C143998085 @default.
• W4224440106 hasConcept C207103383 @default.
• W4224440106 hasConcept C2776694085 @default.
• W4224440106 hasConcept C2776755627 @default.
• W4224440106 hasConcept C2777872185 @default.
• W4224440106 hasConcept C2778191690 @default.
• W4224440106 hasConcept C2778720950 @default.
• W4224440106 hasConcept C2779338263 @default.
• W4224440106 hasConcept C2779429289 @default.
• W4224440106 hasConcept C2780739268 @default.
• W4224440106 hasConcept C44249647 @default.
• W4224440106 hasConcept C70905583 @default.
• W4224440106 hasConcept C71924100 @default.
• W4224440106 hasConceptScore W4224440106C126322002 @default.
• W4224440106 hasConceptScore W4224440106C143998085 @default.
• W4224440106 hasConceptScore W4224440106C207103383 @default.

• next